NCT02715284 · Interventional trial
Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors
Overall registry status Active not recruiting
Phase 1
Conditions Neoplasms
Delaware Valley sites
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory